Mixed connective tissue disease historical perspective

Jump to navigation Jump to search

Mixed connective tissue disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Mixed connective tissue disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Mixed connective tissue disease historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Mixed connective tissue disease historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

National Guidelines Clearinghouse

NICE Guidance

FDA on Mixed connective tissue disease historical perspective

on Mixed connective tissue disease historical perspective

Mixed connective tissue disease historical perspective in the news

Blogs onMixed connective tissue disease historical perspective

Directions to Hospitals Treating Mixed connective tissue disease

Risk calculators and risk factors for Mixed connective tissue disease historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shaghayegh Habibi, M.D.[2]

Overview

In 1972, Gordon C.Sharp was the first physician who defined MCTD. It has been the first rheumatic disease syndrome that has represented by a serologic test. In 1976, Alarcon-Segovia proposed criteria for MCTD classifying between all types of connective tissue diseases. It represents the close association between MCTD and Sjogren's syndrome.

Historical Perspective

  • In 1972, Gordon C.Sharp was the first physician who defined MCTD.
  • MCTD has been the first rheumatic disease syndrome that has represented by a serologic test (positive U1RNP).[1][2]
  • In 1976, Alarcon-Segovia proposed criteria for MCTD classifying between all types of connective tissue diseases. It represents the close association between MCTD and Sjogren's syndrome.
  • In 1987, Sharp, Alarcon-Segovia and The Research Committee of Japanese Ministry of Health and Welfare for MCTD (JMHW) suggested three groups of criteria for diagnosing MCTD.[3]

References

  1. Vij M, Agrawal V, Jain M (July 2014). "Scleroderma renal crisis in a case of mixed connective tissue disease". Saudi J Kidney Dis Transpl. 25 (4): 844–8. PMID 24969199.
  2. Hoffman RW, Maldonado ME (July 2008). "Immune pathogenesis of Mixed Connective Tissue Disease: a short analytical review". Clin. Immunol. 128 (1): 8–17. doi:10.1016/j.clim.2008.03.461. PMID 18439877.
  3. Alarcón-Segovia D (October 1984). "Symptomatic Sjögren's syndrome in mixed connective tissue disease". J. Rheumatol. 11 (5): 582–3. PMID 6512789.

Template:WH Template:WS